Skip to main content

Novartis strikes deal with UK to provide cholesterol drug to high-risk patients

The Swiss drugmaker will provide the drug to patients with Atherosclerosis, a heart disease in which plaque builds up inside arteries and can lead to issues, including heart attack or death.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.